Sight Sciences, Inc. (SGHT) — SEC Financial Statements & Analysis

Sight Sciences, Inc. (SGHT) is a surgical & medical instruments & apparatus company, incorporated in DE. Sight Sciences, Inc. trades on Nasdaq as: SGHT. Sight Sciences, Inc. (SGHT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Sight Sciences, Inc. carries a market cap of $295.42M, a P/E ratio of -9.93x, a P/B ratio of 5.59x, a P/S ratio of 3.54x, an enterprise value of $256.18M, and an EV/EBITDA multiple of -9.33x. On profitability, it posts a gross margin of 87.96%, an operating margin of -33.43%, a net margin of -35.69%, a Return on Equity (ROE) of -48.42%, a Return on Assets (ROA) of -26.24%, and a Return on Invested Capital (ROIC) of -221.20%. Per share, it reports EPS of $-0.55, diluted EPS of $-0.55, free cash flow per share of $-0.43, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 9.27% year-over-year, net income growth of -39.28% year-over-year, and EPS growth of -42.27% year-over-year. On the balance sheet, it maintains a current ratio of 4.95x, a quick ratio of 4.45x, working capital of $80.94M, a debt-to-equity ratio of 0.98x, a debt ratio of 0.5, an interest coverage ratio of -5.41x, free cash flow of $-23.64M (TTM), and net debt of $-39.24M. Figures sourced from SEC EDGAR.

Market Cap

$295.42M

P/E TTM

-9.93x

EPS TTM

$-0.55

P/B TTM

5.59x

ROE TTM

-48.42%

ROA TTM

-26.24%

Debt To Equity

0.98x

Free Cash Flow TTM

$-23.64M

Net Revenue TTM Growth 1Y

9.27%

Data as of 2026-06-30 · Source: SEC EDGAR